104 related articles for article (PubMed ID: 1841819)
21. How does glibenclamide lower plasma glucose concentration in patients with type 2 diabetes?
Jeng CY; Hollenbeck CB; Wu MS; Chen YD; Reaven GM
Diabet Med; 1989; 6(4):303-8. PubMed ID: 2524334
[TBL] [Abstract][Full Text] [Related]
22. Influence of insulin on glucose metabolism and energy expenditure in septic patients.
Rusavy Z; Sramek V; Lacigova S; Novak I; Tesinsky P; Macdonald IA
Crit Care; 2004 Aug; 8(4):R213-20. PubMed ID: 15312220
[TBL] [Abstract][Full Text] [Related]
23. Sulphonylurea therapy doubles B-cell response to glucose in type 2 diabetic patients.
Hosker JP; Burnett MA; Davies EG; Harris EA; Turner RC
Diabetologia; 1985 Nov; 28(11):809-14. PubMed ID: 3936738
[TBL] [Abstract][Full Text] [Related]
24. A randomized crossover study of sulphonylurea and insulin treatment in patients with type 2 diabetes poorly controlled on dietary therapy.
Wolffenbuttel BH; Weber RF; van Koetsveld PM; Weeks L; Verschoor L
Diabet Med; 1989 Aug; 6(6):520-5. PubMed ID: 2527134
[TBL] [Abstract][Full Text] [Related]
25. Mode of action of chloroquine in patients with non-insulin-dependent diabetes mellitus.
Powrie JK; Smith GD; Shojaee-Moradie F; Sönksen PH; Jones RH
Am J Physiol; 1991 Jun; 260(6 Pt 1):E897-904. PubMed ID: 2058666
[TBL] [Abstract][Full Text] [Related]
26. Preoperative glucose and protein metabolism: the influence of diabetes mellitus type 2 in patients with colorectal tumors.
Lugli AK; Donatelli F; Schricker T; Wykes L; Carli F
Nutr Cancer; 2011; 63(6):924-9. PubMed ID: 21745052
[TBL] [Abstract][Full Text] [Related]
27. Ketone bodies as markers for type 1 (insulin-dependent) diabetes and their value in the monitoring of diabetic control.
Harano Y; Kosugi K; Hyosu T; Suzuki M; Hidaka H; Kashiwagi A; Uno S; Shigeta Y
Diabetologia; 1984 May; 26(5):343-8. PubMed ID: 6376243
[TBL] [Abstract][Full Text] [Related]
28. Glyburide in non-insulin-dependent diabetes. Its therapeutic effect in patients with disease poorly controlled by insulin alone.
Lardinois CK; Liu GC; Reaven GM
Arch Intern Med; 1985 Jun; 145(6):1028-32. PubMed ID: 3923961
[TBL] [Abstract][Full Text] [Related]
29. Maintenance of basal insulin secretion in severe non-insulin-dependent diabetes.
Kingston ME; Skoog WC
Diabetes Care; 1986; 9(3):232-5. PubMed ID: 3525054
[TBL] [Abstract][Full Text] [Related]
30. Energy expenditure in non-insulin dependent diabetic subjects on metformin or sulphonylurea therapy.
Leslie P; Jung RT; Isles TE; Baty J
Clin Sci (Lond); 1987 Jul; 73(1):41-5. PubMed ID: 3301165
[TBL] [Abstract][Full Text] [Related]
31. Thermogenic effect of slight hyperglycemia during a lipid infusion.
Rigalleau V; Beylot M; Laville M; Pachiaudi C; Normand S; Nlend E; Gin H
Metabolism; 1999 Mar; 48(3):278-84. PubMed ID: 10094100
[TBL] [Abstract][Full Text] [Related]
32. Alterations in non-insulin-mediated glucose uptake in the elderly patient with diabetes.
Forbes A; Elliott T; Tildesley H; Finegood D; Meneilly GS
Diabetes; 1998 Dec; 47(12):1915-9. PubMed ID: 9836524
[TBL] [Abstract][Full Text] [Related]
33. A comparative study of sulphonylurea and insulin therapy in non insulin dependent diabetics who had failed on diet therapy alone.
Samanta A; Burden AC; Kinghorn HA
Diabetes Res; 1987 Apr; 4(4):183-5. PubMed ID: 3304783
[TBL] [Abstract][Full Text] [Related]
34. The development of hyperglycaemia in patients with insulin-resistant generalized lipoatrophic syndromes.
Robert JJ; Rakotoambinina B; Cochet I; Foussier V; Magre J; Darmaun D; Chevenne D; Capeau J
Diabetologia; 1993 Dec; 36(12):1288-92. PubMed ID: 8307257
[TBL] [Abstract][Full Text] [Related]
35. Effects of hypocaloric diet and insulin therapy on metabolic control and mechanisms of hyperglycemia in obese non-insulin-dependent diabetic subjects.
Laakso M; Uusitupa M; Takala J; Majander H; Reijonen T; Penttilä I
Metabolism; 1988 Nov; 37(11):1092-100. PubMed ID: 3054433
[TBL] [Abstract][Full Text] [Related]
36. Effects of dexfenfluramine on glucose turnover in non-insulin-dependent diabetes mellitus.
Proietto J; Thorburn AW; Fabris S; Harrison LC
Diabetes Res Clin Pract; 1994 Mar; 23(2):127-34. PubMed ID: 8070304
[TBL] [Abstract][Full Text] [Related]
37. Low-dose oral glyburide reduces fasting blood glucose by decreasing hepatic glucose production in healthy volunteers without increasing carbohydrate oxidation.
Tayek JA
Am J Med Sci; 1995 Mar; 309(3):134-9. PubMed ID: 7879817
[TBL] [Abstract][Full Text] [Related]
38. Assessment of non-insulin-mediated glucose uptake: association with body fat and glycemic status.
Jumpertz R; Thearle MS; Bunt JC; Krakoff J
Metabolism; 2010 Oct; 59(10):1396-401. PubMed ID: 20153490
[TBL] [Abstract][Full Text] [Related]
39. [Management of patients with impaired glucose tolerance following esophagectomy in carcinoma of the esophagus].
Sato N; Matsubara Y; Tanaka O; Muto T
Nihon Geka Gakkai Zasshi; 1992 Sep; 93(9):977-80. PubMed ID: 1470165
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of glucose metabolism in Nordic and South Asian subjects with type 2 diabetes.
Wium C; Gulseth HL; Eriksen EF; Birkeland KI
PLoS One; 2013; 8(12):e83983. PubMed ID: 24391858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
